Andexanet Alfa: A Recombinant Modified Human Factor Xa Protein for Drug Reversal of Rivaroxaban and Apixaban

Objective: To review the pharmacology, safety, and efficacy of andexanet alfa (andexanet), a recombinant modified human factor Xa protein for reversal of factor Xa inhibitors. Data Sources: English-language articles were obtained from MEDLINE (1966 to February 2019) using the following key words: an...

Full description

Saved in:
Bibliographic Details
Published in:J Pharm Technol
Main Authors: Abuan, Irene, Wong, Kristine H., Bolinske, Benjamin, Hale, Katherine S.
Format: Artigo
Language:Inglês
Published: SAGE Publications 2019
Subjects:
Review Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6488727/
https://ncbi.nlm.nih.gov/pubmed/34860981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122519839437
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items